“…Small intestine (SI)-derived DC-enriched cells were isolated as previously described [1,8]. The cells were stained with fluorescein isothiocyanate (FITC)-conjugated mAb against CD11c (BD Biosciences, San Jose, CA), phycoerythrin (PE)-conjugated anti-CD11c, -CD103, PIR-A/B (BD Biosciences), PIR-B (clone 326414: R&D Systems, Inc., Minneapolis, USA), and allophycocyanin (APC)-conjugated anti-CD45R (B220) (BD Biosciences), -CD11b, -CD83 mAbs (eBioscience Inc., San Diego, CA), -CD40, -CD86, and -CD197 mAbs (CCR7), Alexa Fluor 647-conjugated anti-CD54 mAbs, PE/Cy7-conjugated anti-CD86 mAbs (BioLegend, San Diego, CA, USA), -CD45R (B220) (BD Biosciences), PIR-A/B (BD Biosciences), and anti-CX3CR1 Abs (ProSci inc., Flint Place Poway, CA, USA).…”